Intensive blood pressure control in type 2 diabetes: a meta-analysis of randomized controlled trials.
Updated evidence guides optimal blood pressure targets in diabetes, helping personalize treatment for cardiovascular risk reduction.
This updated meta-analysis of RCTs evaluates intensive vs standard blood pressure targets in type 2 diabetes, providing quantitative effect estimates for MACE, stroke, and renal outcomes across different BP thresholds. The risk-benefit analysis informs guideline decisions on optimal BP targets in T2DM, particularly relevant given ongoing debates following the ACCORD and SPRINT trials.
What the study was
- Study design
- Meta-analysis of randomized controlled trials
- Category
- Prevention
- Maturity
- Validated
- Journal
- Front Endocrinol (Lausanne)
Why it surfaced
RCT-level meta-analysis on clinically important BP target question in T2DM; directly relevant to cardiometabolic watchlist; addresses ongoing clinical controversy.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.